EP Wealth Advisors LLC Acquires 1,867 Shares of McKesson Co. (NYSE:MCK)

EP Wealth Advisors LLC grew its holdings in McKesson Co. (NYSE:MCK - Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,125 shares of the company's stock after buying an additional 1,867 shares during the quarter. EP Wealth Advisors LLC's holdings in McKesson were worth $14,889,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Colonial Trust Co SC raised its stake in shares of McKesson by 30.3% during the fourth quarter. Colonial Trust Co SC now owns 447 shares of the company's stock worth $255,000 after buying an additional 104 shares during the last quarter. BOKF NA raised its position in shares of McKesson by 5.8% during the 4th quarter. BOKF NA now owns 1,147 shares of the company's stock valued at $667,000 after acquiring an additional 63 shares during the last quarter. Brevan Howard Capital Management LP lifted its stake in shares of McKesson by 30.1% in the 4th quarter. Brevan Howard Capital Management LP now owns 10,524 shares of the company's stock valued at $5,998,000 after purchasing an additional 2,434 shares during the period. Captrust Financial Advisors boosted its position in shares of McKesson by 4.9% in the 4th quarter. Captrust Financial Advisors now owns 37,266 shares of the company's stock worth $21,238,000 after purchasing an additional 1,736 shares during the last quarter. Finally, Cary Street Partners Financial LLC acquired a new stake in shares of McKesson during the fourth quarter worth $108,000. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Activity at McKesson

In other McKesson news, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares of the company's stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the transaction, the chief executive officer now owns 60,664 shares in the company, valued at approximately $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,110 shares of company stock valued at $10,855,706 over the last quarter. 0.11% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Bank of America raised their target price on McKesson from $665.00 to $755.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Morgan Stanley boosted their price objective on shares of McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. UBS Group increased their target price on shares of McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Mizuho upped their price objective on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Finally, StockNews.com downgraded McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, McKesson currently has an average rating of "Moderate Buy" and an average price target of $681.00.

McKesson Stock Up 1.5 %

Shares of MCK opened at $721.98 on Thursday. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $729.40. The stock has a market capitalization of $90.48 billion, a P/E ratio of 33.06, a P/E/G ratio of 1.29 and a beta of 0.53. The company has a 50 day moving average of $676.31 and a 200-day moving average of $617.52.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, sell-side analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd will be issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.39%. The ex-dividend date is Monday, June 2nd. McKesson's dividend payout ratio (DPR) is currently 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.